PIK3CA mutations in advanced ovarian carcinomas.

Human mutation

Volumn 25, Issue 3, 2005, Pages 322-

  Wang, Yun ^a   Helland, Aslaug ^a   Holm, Ruth ^a   Kristensen, Gunnar B ^a   Børresen Dale, Anne Lise ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PIK3CA PROTEIN, HUMAN;

ADENOCARCINOMA; AGED; ARTICLE; CARCINOMA; CELL TRANSFORMATION; CYSTADENOCARCINOMA; DNA SEQUENCE; DRUG EFFECT; ENZYME ACTIVATION; EXON; FEMALE; GENETICS; HUMAN; LIFE TABLE; MIDDLE AGED; MISSENSE MUTATION; MORTALITY; NUCLEOTIDE SEQUENCE; OVARY TUMOR; POINT MUTATION; SURVIVAL RATE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADENOCARCINOMA, CLEAR CELL; AGED; CARCINOMA; CELL TRANSFORMATION, NEOPLASTIC; CYSTADENOCARCINOMA, MUCINOUS; CYSTADENOCARCINOMA, SEROUS; DNA MUTATIONAL ANALYSIS; ENZYME ACTIVATION; EXONS; FEMALE; HUMANS; LIFE TABLES; MIDDLE AGED; MUTATION, MISSENSE; OVARIAN NEOPLASMS; POINT MUTATION; SEQUENCE ANALYSIS, DNA; SURVIVAL RATE;

MLCS; MLOWN;

EID: 24144452026     PISSN: None     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.9316     Document Type: Article

References (0)